nodes	percent_of_prediction	percent_of_DWPC	metapath
Ritonavir—CYP3A4—bone cancer	0.275	1	CbGaD
Ritonavir—ABCC1—Epirubicin—bone cancer	0.0628	0.12	CbGbCtD
Ritonavir—ABCC2—Carboplatin—bone cancer	0.0432	0.0827	CbGbCtD
Ritonavir—ABCG2—Carboplatin—bone cancer	0.039	0.0748	CbGbCtD
Ritonavir—ABCC2—Cisplatin—bone cancer	0.0369	0.0707	CbGbCtD
Ritonavir—ABCC1—Doxorubicin—bone cancer	0.0334	0.064	CbGbCtD
Ritonavir—ABCG2—Cisplatin—bone cancer	0.0334	0.0639	CbGbCtD
Ritonavir—ABCC1—Methotrexate—bone cancer	0.0324	0.062	CbGbCtD
Ritonavir—SLCO1A2—Methotrexate—bone cancer	0.0289	0.0554	CbGbCtD
Ritonavir—SLCO1B1—Methotrexate—bone cancer	0.0273	0.0522	CbGbCtD
Ritonavir—ABCC2—Doxorubicin—bone cancer	0.0247	0.0474	CbGbCtD
Ritonavir—ABCC2—Methotrexate—bone cancer	0.0239	0.0459	CbGbCtD
Ritonavir—CYP2B6—Cisplatin—bone cancer	0.0235	0.045	CbGbCtD
Ritonavir—ABCG2—Doxorubicin—bone cancer	0.0224	0.0428	CbGbCtD
Ritonavir—ABCG2—Methotrexate—bone cancer	0.0217	0.0415	CbGbCtD
Ritonavir—CYP2B6—Doxorubicin—bone cancer	0.0157	0.0301	CbGbCtD
Ritonavir—CYP2C9—Cisplatin—bone cancer	0.0124	0.0238	CbGbCtD
Ritonavir—ABCB1—Cisplatin—bone cancer	0.012	0.023	CbGbCtD
Ritonavir—ABCB1—Doxorubicin—bone cancer	0.00806	0.0154	CbGbCtD
Ritonavir—ABCB1—Methotrexate—bone cancer	0.00781	0.015	CbGbCtD
Ritonavir—CYP2D6—Doxorubicin—bone cancer	0.00759	0.0146	CbGbCtD
Ritonavir—CYP3A4—Doxorubicin—bone cancer	0.00483	0.00925	CbGbCtD
Ritonavir—Atazanavir—CYP3A4—bone cancer	0.00143	0.584	CrCbGaD
Ritonavir—Lopinavir—CYP3A4—bone cancer	0.00102	0.416	CrCbGaD
Ritonavir—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000201	0.00328	CbGpPWpGaD
Ritonavir—CYP2C9—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000197	0.00321	CbGpPWpGaD
Ritonavir—CYP3A7—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.00019	0.00309	CbGpPWpGaD
Ritonavir—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000188	0.00306	CbGpPWpGaD
Ritonavir—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000173	0.00282	CbGpPWpGaD
Ritonavir—CYP2B6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000171	0.00278	CbGpPWpGaD
Ritonavir—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000169	0.00276	CbGpPWpGaD
Ritonavir—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000169	0.00276	CbGpPWpGaD
Ritonavir—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000169	0.00275	CbGpPWpGaD
Ritonavir—CYP2E1—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000167	0.00273	CbGpPWpGaD
Ritonavir—CYP3A5—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000167	0.00272	CbGpPWpGaD
Ritonavir—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	0.000162	0.00264	CbGpPWpGaD
Ritonavir—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.00016	0.00262	CbGpPWpGaD
Ritonavir—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000147	0.00239	CbGpPWpGaD
Ritonavir—CYP2C8—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000145	0.00236	CbGpPWpGaD
Ritonavir—CYP2B6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.00014	0.00229	CbGpPWpGaD
Ritonavir—CYP1A2—Estrogen Receptor Pathway—JUN—bone cancer	0.000138	0.00226	CbGpPWpGaD
Ritonavir—ABCC1—Arachidonic acid metabolism—PTGS2—bone cancer	0.000138	0.00224	CbGpPWpGaD
Ritonavir—CYP2E1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000137	0.00224	CbGpPWpGaD
Ritonavir—CYP3A5—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000137	0.00224	CbGpPWpGaD
Ritonavir—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000131	0.00213	CbGpPWpGaD
Ritonavir—Hepatobiliary disease—Epirubicin—bone cancer	0.000129	0.000925	CcSEcCtD
Ritonavir—CYP2C19—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000129	0.0021	CbGpPWpGaD
Ritonavir—Epistaxis—Epirubicin—bone cancer	0.000129	0.000923	CcSEcCtD
Ritonavir—Urethral disorder—Methotrexate—bone cancer	0.000128	0.00092	CcSEcCtD
Ritonavir—Weight decreased—Doxorubicin—bone cancer	0.000128	0.000919	CcSEcCtD
Ritonavir—Sinusitis—Epirubicin—bone cancer	0.000128	0.000918	CcSEcCtD
Ritonavir—Hyperglycaemia—Doxorubicin—bone cancer	0.000128	0.000916	CcSEcCtD
Ritonavir—Visual impairment—Methotrexate—bone cancer	0.000126	0.000904	CcSEcCtD
Ritonavir—CYP1A2—Tryptophan metabolism—CYP3A4—bone cancer	0.000126	0.00205	CbGpPWpGaD
Ritonavir—Hypersensitivity—Cisplatin—bone cancer	0.000125	0.000895	CcSEcCtD
Ritonavir—Renal failure—Doxorubicin—bone cancer	0.000124	0.00089	CcSEcCtD
Ritonavir—Erythema multiforme—Methotrexate—bone cancer	0.000124	0.000887	CcSEcCtD
Ritonavir—Neuropathy peripheral—Doxorubicin—bone cancer	0.000124	0.000887	CcSEcCtD
Ritonavir—Haemoglobin—Epirubicin—bone cancer	0.000123	0.000883	CcSEcCtD
Ritonavir—Jaundice—Doxorubicin—bone cancer	0.000123	0.000882	CcSEcCtD
Ritonavir—Stomatitis—Doxorubicin—bone cancer	0.000123	0.000882	CcSEcCtD
Ritonavir—Rhinitis—Epirubicin—bone cancer	0.000123	0.000881	CcSEcCtD
Ritonavir—Urinary tract infection—Doxorubicin—bone cancer	0.000123	0.00088	CcSEcCtD
Ritonavir—Conjunctivitis—Doxorubicin—bone cancer	0.000123	0.00088	CcSEcCtD
Ritonavir—Haemorrhage—Epirubicin—bone cancer	0.000123	0.000878	CcSEcCtD
Ritonavir—Hepatitis—Epirubicin—bone cancer	0.000123	0.000878	CcSEcCtD
Ritonavir—Eye disorder—Methotrexate—bone cancer	0.000122	0.000877	CcSEcCtD
Ritonavir—Tinnitus—Methotrexate—bone cancer	0.000122	0.000875	CcSEcCtD
Ritonavir—Hypoaesthesia—Epirubicin—bone cancer	0.000122	0.000874	CcSEcCtD
Ritonavir—Asthenia—Cisplatin—bone cancer	0.000122	0.000872	CcSEcCtD
Ritonavir—Pharyngitis—Epirubicin—bone cancer	0.000122	0.000872	CcSEcCtD
Ritonavir—Cardiac disorder—Methotrexate—bone cancer	0.000122	0.000871	CcSEcCtD
Ritonavir—Sweating—Doxorubicin—bone cancer	0.000121	0.000868	CcSEcCtD
Ritonavir—Urinary tract disorder—Epirubicin—bone cancer	0.000121	0.000867	CcSEcCtD
Ritonavir—Oedema peripheral—Epirubicin—bone cancer	0.000121	0.000865	CcSEcCtD
Ritonavir—Haematuria—Doxorubicin—bone cancer	0.000121	0.000863	CcSEcCtD
Ritonavir—Connective tissue disorder—Epirubicin—bone cancer	0.000121	0.000863	CcSEcCtD
Ritonavir—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.00012	0.00196	CbGpPWpGaD
Ritonavir—Urethral disorder—Epirubicin—bone cancer	0.00012	0.000861	CcSEcCtD
Ritonavir—Hepatobiliary disease—Doxorubicin—bone cancer	0.00012	0.000856	CcSEcCtD
Ritonavir—Epistaxis—Doxorubicin—bone cancer	0.000119	0.000854	CcSEcCtD
Ritonavir—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000119	0.00194	CbGpPWpGaD
Ritonavir—Angiopathy—Methotrexate—bone cancer	0.000119	0.000852	CcSEcCtD
Ritonavir—CYP2C8—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000119	0.00194	CbGpPWpGaD
Ritonavir—CYP2D6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000119	0.00193	CbGpPWpGaD
Ritonavir—Sinusitis—Doxorubicin—bone cancer	0.000119	0.000849	CcSEcCtD
Ritonavir—Immune system disorder—Methotrexate—bone cancer	0.000118	0.000848	CcSEcCtD
Ritonavir—Visual impairment—Epirubicin—bone cancer	0.000118	0.000846	CcSEcCtD
Ritonavir—Mediastinal disorder—Methotrexate—bone cancer	0.000118	0.000846	CcSEcCtD
Ritonavir—CYP2C9—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000118	0.00192	CbGpPWpGaD
Ritonavir—Chills—Methotrexate—bone cancer	0.000118	0.000842	CcSEcCtD
Ritonavir—Diarrhoea—Cisplatin—bone cancer	0.000116	0.000831	CcSEcCtD
Ritonavir—Erythema multiforme—Epirubicin—bone cancer	0.000116	0.00083	CcSEcCtD
Ritonavir—Mental disorder—Methotrexate—bone cancer	0.000115	0.000822	CcSEcCtD
Ritonavir—Eye disorder—Epirubicin—bone cancer	0.000115	0.000821	CcSEcCtD
Ritonavir—Tinnitus—Epirubicin—bone cancer	0.000114	0.000819	CcSEcCtD
Ritonavir—Malnutrition—Methotrexate—bone cancer	0.000114	0.000817	CcSEcCtD
Ritonavir—Haemoglobin—Doxorubicin—bone cancer	0.000114	0.000817	CcSEcCtD
Ritonavir—ABCC2—NRF2 pathway—TGFBR2—bone cancer	0.000114	0.00186	CbGpPWpGaD
Ritonavir—ABCC2—NRF2 pathway—GSTP1—bone cancer	0.000114	0.00186	CbGpPWpGaD
Ritonavir—Cardiac disorder—Epirubicin—bone cancer	0.000114	0.000815	CcSEcCtD
Ritonavir—Flushing—Epirubicin—bone cancer	0.000114	0.000815	CcSEcCtD
Ritonavir—Rhinitis—Doxorubicin—bone cancer	0.000114	0.000815	CcSEcCtD
Ritonavir—Haemorrhage—Doxorubicin—bone cancer	0.000113	0.000813	CcSEcCtD
Ritonavir—Hepatitis—Doxorubicin—bone cancer	0.000113	0.000813	CcSEcCtD
Ritonavir—Hypoaesthesia—Doxorubicin—bone cancer	0.000113	0.000809	CcSEcCtD
Ritonavir—Pharyngitis—Doxorubicin—bone cancer	0.000113	0.000807	CcSEcCtD
Ritonavir—Urinary tract disorder—Doxorubicin—bone cancer	0.000112	0.000803	CcSEcCtD
Ritonavir—Oedema peripheral—Doxorubicin—bone cancer	0.000112	0.000801	CcSEcCtD
Ritonavir—Dysgeusia—Methotrexate—bone cancer	0.000112	0.0008	CcSEcCtD
Ritonavir—Connective tissue disorder—Doxorubicin—bone cancer	0.000112	0.000799	CcSEcCtD
Ritonavir—Angiopathy—Epirubicin—bone cancer	0.000111	0.000797	CcSEcCtD
Ritonavir—Urethral disorder—Doxorubicin—bone cancer	0.000111	0.000797	CcSEcCtD
Ritonavir—Immune system disorder—Epirubicin—bone cancer	0.000111	0.000793	CcSEcCtD
Ritonavir—Mediastinal disorder—Epirubicin—bone cancer	0.000111	0.000792	CcSEcCtD
Ritonavir—Back pain—Methotrexate—bone cancer	0.00011	0.00079	CcSEcCtD
Ritonavir—Chills—Epirubicin—bone cancer	0.00011	0.000788	CcSEcCtD
Ritonavir—Visual impairment—Doxorubicin—bone cancer	0.000109	0.000783	CcSEcCtD
Ritonavir—Vomiting—Cisplatin—bone cancer	0.000108	0.000773	CcSEcCtD
Ritonavir—Vision blurred—Methotrexate—bone cancer	0.000108	0.00077	CcSEcCtD
Ritonavir—Mental disorder—Epirubicin—bone cancer	0.000107	0.000769	CcSEcCtD
Ritonavir—Erythema multiforme—Doxorubicin—bone cancer	0.000107	0.000768	CcSEcCtD
Ritonavir—Rash—Cisplatin—bone cancer	0.000107	0.000766	CcSEcCtD
Ritonavir—Dermatitis—Cisplatin—bone cancer	0.000107	0.000765	CcSEcCtD
Ritonavir—Malnutrition—Epirubicin—bone cancer	0.000107	0.000765	CcSEcCtD
Ritonavir—Eye disorder—Doxorubicin—bone cancer	0.000106	0.000759	CcSEcCtD
Ritonavir—CYP2C19—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000106	0.00173	CbGpPWpGaD
Ritonavir—Ill-defined disorder—Methotrexate—bone cancer	0.000106	0.000758	CcSEcCtD
Ritonavir—Tinnitus—Doxorubicin—bone cancer	0.000106	0.000758	CcSEcCtD
Ritonavir—Anaemia—Methotrexate—bone cancer	0.000105	0.000755	CcSEcCtD
Ritonavir—Flushing—Doxorubicin—bone cancer	0.000105	0.000754	CcSEcCtD
Ritonavir—Cardiac disorder—Doxorubicin—bone cancer	0.000105	0.000754	CcSEcCtD
Ritonavir—Flatulence—Epirubicin—bone cancer	0.000105	0.000753	CcSEcCtD
Ritonavir—Tension—Epirubicin—bone cancer	0.000105	0.00075	CcSEcCtD
Ritonavir—Dysgeusia—Epirubicin—bone cancer	0.000105	0.000749	CcSEcCtD
Ritonavir—Nervousness—Epirubicin—bone cancer	0.000104	0.000743	CcSEcCtD
Ritonavir—Back pain—Epirubicin—bone cancer	0.000103	0.00074	CcSEcCtD
Ritonavir—Angiopathy—Doxorubicin—bone cancer	0.000103	0.000737	CcSEcCtD
Ritonavir—Malaise—Methotrexate—bone cancer	0.000103	0.000737	CcSEcCtD
Ritonavir—Muscle spasms—Epirubicin—bone cancer	0.000103	0.000735	CcSEcCtD
Ritonavir—Immune system disorder—Doxorubicin—bone cancer	0.000103	0.000734	CcSEcCtD
Ritonavir—Vertigo—Methotrexate—bone cancer	0.000103	0.000734	CcSEcCtD
Ritonavir—Mediastinal disorder—Doxorubicin—bone cancer	0.000102	0.000732	CcSEcCtD
Ritonavir—Leukopenia—Methotrexate—bone cancer	0.000102	0.000731	CcSEcCtD
Ritonavir—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000102	0.00166	CbGpPWpGaD
Ritonavir—Chills—Doxorubicin—bone cancer	0.000102	0.000729	CcSEcCtD
Ritonavir—Nausea—Cisplatin—bone cancer	0.000101	0.000722	CcSEcCtD
Ritonavir—CYP3A7—Biological oxidations—CYP3A4—bone cancer	0.000101	0.00164	CbGpPWpGaD
Ritonavir—Vision blurred—Epirubicin—bone cancer	0.000101	0.000721	CcSEcCtD
Ritonavir—CYP1A2—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000101	0.00164	CbGpPWpGaD
Ritonavir—ABCG2—Fluoropyrimidine Activity—TP53—bone cancer	0.0001	0.00164	CbGpPWpGaD
Ritonavir—Cough—Methotrexate—bone cancer	9.96e-05	0.000713	CcSEcCtD
Ritonavir—Mental disorder—Doxorubicin—bone cancer	9.94e-05	0.000712	CcSEcCtD
Ritonavir—CYP3A7—Metapathway biotransformation—CYP3A4—bone cancer	9.94e-05	0.00162	CbGpPWpGaD
Ritonavir—Ill-defined disorder—Epirubicin—bone cancer	9.91e-05	0.000709	CcSEcCtD
Ritonavir—Convulsion—Methotrexate—bone cancer	9.89e-05	0.000708	CcSEcCtD
Ritonavir—Malnutrition—Doxorubicin—bone cancer	9.88e-05	0.000707	CcSEcCtD
Ritonavir—Anaemia—Epirubicin—bone cancer	9.87e-05	0.000707	CcSEcCtD
Ritonavir—SLCO1A2—Transmembrane transport of small molecules—TUBB4B—bone cancer	9.84e-05	0.0016	CbGpPWpGaD
Ritonavir—Agitation—Epirubicin—bone cancer	9.81e-05	0.000703	CcSEcCtD
Ritonavir—CYP2D6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	9.75e-05	0.00159	CbGpPWpGaD
Ritonavir—Flatulence—Doxorubicin—bone cancer	9.74e-05	0.000697	CcSEcCtD
Ritonavir—Arthralgia—Methotrexate—bone cancer	9.71e-05	0.000696	CcSEcCtD
Ritonavir—Chest pain—Methotrexate—bone cancer	9.71e-05	0.000696	CcSEcCtD
Ritonavir—Myalgia—Methotrexate—bone cancer	9.71e-05	0.000696	CcSEcCtD
Ritonavir—Tension—Doxorubicin—bone cancer	9.69e-05	0.000694	CcSEcCtD
Ritonavir—Dysgeusia—Doxorubicin—bone cancer	9.67e-05	0.000693	CcSEcCtD
Ritonavir—CYP2C9—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	9.67e-05	0.00158	CbGpPWpGaD
Ritonavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	9.65e-05	0.000691	CcSEcCtD
Ritonavir—CYP2E1—Tryptophan metabolism—MDM2—bone cancer	9.64e-05	0.00157	CbGpPWpGaD
Ritonavir—Malaise—Epirubicin—bone cancer	9.63e-05	0.00069	CcSEcCtD
Ritonavir—Discomfort—Methotrexate—bone cancer	9.6e-05	0.000687	CcSEcCtD
Ritonavir—Nervousness—Doxorubicin—bone cancer	9.6e-05	0.000687	CcSEcCtD
Ritonavir—Vertigo—Epirubicin—bone cancer	9.59e-05	0.000687	CcSEcCtD
Ritonavir—Syncope—Epirubicin—bone cancer	9.58e-05	0.000686	CcSEcCtD
Ritonavir—Leukopenia—Epirubicin—bone cancer	9.56e-05	0.000684	CcSEcCtD
Ritonavir—Back pain—Doxorubicin—bone cancer	9.56e-05	0.000684	CcSEcCtD
Ritonavir—Muscle spasms—Doxorubicin—bone cancer	9.5e-05	0.00068	CcSEcCtD
Ritonavir—Palpitations—Epirubicin—bone cancer	9.44e-05	0.000676	CcSEcCtD
Ritonavir—Confusional state—Methotrexate—bone cancer	9.39e-05	0.000672	CcSEcCtD
Ritonavir—Loss of consciousness—Epirubicin—bone cancer	9.38e-05	0.000672	CcSEcCtD
Ritonavir—Cough—Epirubicin—bone cancer	9.32e-05	0.000667	CcSEcCtD
Ritonavir—Vision blurred—Doxorubicin—bone cancer	9.31e-05	0.000667	CcSEcCtD
Ritonavir—Convulsion—Epirubicin—bone cancer	9.25e-05	0.000662	CcSEcCtD
Ritonavir—Hypertension—Epirubicin—bone cancer	9.22e-05	0.00066	CcSEcCtD
Ritonavir—Ill-defined disorder—Doxorubicin—bone cancer	9.17e-05	0.000656	CcSEcCtD
Ritonavir—Nervous system disorder—Methotrexate—bone cancer	9.13e-05	0.000654	CcSEcCtD
Ritonavir—Anaemia—Doxorubicin—bone cancer	9.13e-05	0.000654	CcSEcCtD
Ritonavir—Thrombocytopenia—Methotrexate—bone cancer	9.12e-05	0.000653	CcSEcCtD
Ritonavir—Myalgia—Epirubicin—bone cancer	9.09e-05	0.000651	CcSEcCtD
Ritonavir—Chest pain—Epirubicin—bone cancer	9.09e-05	0.000651	CcSEcCtD
Ritonavir—Arthralgia—Epirubicin—bone cancer	9.09e-05	0.000651	CcSEcCtD
Ritonavir—Agitation—Doxorubicin—bone cancer	9.08e-05	0.00065	CcSEcCtD
Ritonavir—Anxiety—Epirubicin—bone cancer	9.06e-05	0.000649	CcSEcCtD
Ritonavir—Skin disorder—Methotrexate—bone cancer	9.04e-05	0.000648	CcSEcCtD
Ritonavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	9.03e-05	0.000646	CcSEcCtD
Ritonavir—Hyperhidrosis—Methotrexate—bone cancer	9e-05	0.000645	CcSEcCtD
Ritonavir—Discomfort—Epirubicin—bone cancer	8.98e-05	0.000643	CcSEcCtD
Ritonavir—ABCC2—Transmembrane transport of small molecules—TUBB4B—bone cancer	8.96e-05	0.00146	CbGpPWpGaD
Ritonavir—Malaise—Doxorubicin—bone cancer	8.91e-05	0.000638	CcSEcCtD
Ritonavir—Dry mouth—Epirubicin—bone cancer	8.89e-05	0.000637	CcSEcCtD
Ritonavir—Vertigo—Doxorubicin—bone cancer	8.88e-05	0.000636	CcSEcCtD
Ritonavir—Anorexia—Methotrexate—bone cancer	8.88e-05	0.000636	CcSEcCtD
Ritonavir—Syncope—Doxorubicin—bone cancer	8.86e-05	0.000634	CcSEcCtD
Ritonavir—ABCC1—Transmembrane transport of small molecules—TUBB4B—bone cancer	8.86e-05	0.00144	CbGpPWpGaD
Ritonavir—Leukopenia—Doxorubicin—bone cancer	8.84e-05	0.000633	CcSEcCtD
Ritonavir—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—bone cancer	8.83e-05	0.00144	CbGpPWpGaD
Ritonavir—Confusional state—Epirubicin—bone cancer	8.79e-05	0.000629	CcSEcCtD
Ritonavir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	8.76e-05	0.00143	CbGpPWpGaD
Ritonavir—ABCG2—HIF-1-alpha transcription factor network—JUN—bone cancer	8.74e-05	0.00142	CbGpPWpGaD
Ritonavir—Palpitations—Doxorubicin—bone cancer	8.73e-05	0.000625	CcSEcCtD
Ritonavir—Oedema—Epirubicin—bone cancer	8.71e-05	0.000624	CcSEcCtD
Ritonavir—Hypotension—Methotrexate—bone cancer	8.7e-05	0.000623	CcSEcCtD
Ritonavir—Loss of consciousness—Doxorubicin—bone cancer	8.68e-05	0.000622	CcSEcCtD
Ritonavir—Cough—Doxorubicin—bone cancer	8.62e-05	0.000617	CcSEcCtD
Ritonavir—CYP3A7—Biological oxidations—GSTP1—bone cancer	8.62e-05	0.0014	CbGpPWpGaD
Ritonavir—Shock—Epirubicin—bone cancer	8.57e-05	0.000614	CcSEcCtD
Ritonavir—Convulsion—Doxorubicin—bone cancer	8.56e-05	0.000613	CcSEcCtD
Ritonavir—Nervous system disorder—Epirubicin—bone cancer	8.55e-05	0.000612	CcSEcCtD
Ritonavir—Thrombocytopenia—Epirubicin—bone cancer	8.53e-05	0.000611	CcSEcCtD
Ritonavir—Hypertension—Doxorubicin—bone cancer	8.53e-05	0.000611	CcSEcCtD
Ritonavir—Tachycardia—Epirubicin—bone cancer	8.5e-05	0.000609	CcSEcCtD
Ritonavir—CYP3A7—Metapathway biotransformation—GSTP1—bone cancer	8.5e-05	0.00139	CbGpPWpGaD
Ritonavir—SLCO1A2—Transmembrane transport of small molecules—TUBB2A—bone cancer	8.5e-05	0.00139	CbGpPWpGaD
Ritonavir—Musculoskeletal discomfort—Methotrexate—bone cancer	8.48e-05	0.000608	CcSEcCtD
Ritonavir—Skin disorder—Epirubicin—bone cancer	8.46e-05	0.000606	CcSEcCtD
Ritonavir—Hyperhidrosis—Epirubicin—bone cancer	8.42e-05	0.000603	CcSEcCtD
Ritonavir—Insomnia—Methotrexate—bone cancer	8.42e-05	0.000603	CcSEcCtD
Ritonavir—SLCO1B1—Transmembrane transport of small molecules—TUBB4B—bone cancer	8.42e-05	0.00137	CbGpPWpGaD
Ritonavir—Arthralgia—Doxorubicin—bone cancer	8.41e-05	0.000602	CcSEcCtD
Ritonavir—Chest pain—Doxorubicin—bone cancer	8.41e-05	0.000602	CcSEcCtD
Ritonavir—Myalgia—Doxorubicin—bone cancer	8.41e-05	0.000602	CcSEcCtD
Ritonavir—Anxiety—Doxorubicin—bone cancer	8.38e-05	0.0006	CcSEcCtD
Ritonavir—Paraesthesia—Methotrexate—bone cancer	8.36e-05	0.000599	CcSEcCtD
Ritonavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	8.35e-05	0.000598	CcSEcCtD
Ritonavir—Discomfort—Doxorubicin—bone cancer	8.31e-05	0.000595	CcSEcCtD
Ritonavir—Anorexia—Epirubicin—bone cancer	8.31e-05	0.000595	CcSEcCtD
Ritonavir—Dyspnoea—Methotrexate—bone cancer	8.3e-05	0.000594	CcSEcCtD
Ritonavir—Somnolence—Methotrexate—bone cancer	8.28e-05	0.000593	CcSEcCtD
Ritonavir—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	8.26e-05	0.00135	CbGpPWpGaD
Ritonavir—Dry mouth—Doxorubicin—bone cancer	8.23e-05	0.000589	CcSEcCtD
Ritonavir—Dyspepsia—Methotrexate—bone cancer	8.2e-05	0.000587	CcSEcCtD
Ritonavir—Hypotension—Epirubicin—bone cancer	8.14e-05	0.000583	CcSEcCtD
Ritonavir—Confusional state—Doxorubicin—bone cancer	8.13e-05	0.000582	CcSEcCtD
Ritonavir—Decreased appetite—Methotrexate—bone cancer	8.09e-05	0.00058	CcSEcCtD
Ritonavir—Oedema—Doxorubicin—bone cancer	8.06e-05	0.000577	CcSEcCtD
Ritonavir—Gastrointestinal disorder—Methotrexate—bone cancer	8.04e-05	0.000576	CcSEcCtD
Ritonavir—Fatigue—Methotrexate—bone cancer	8.03e-05	0.000575	CcSEcCtD
Ritonavir—Pain—Methotrexate—bone cancer	7.96e-05	0.00057	CcSEcCtD
Ritonavir—Musculoskeletal discomfort—Epirubicin—bone cancer	7.94e-05	0.000569	CcSEcCtD
Ritonavir—Shock—Doxorubicin—bone cancer	7.93e-05	0.000568	CcSEcCtD
Ritonavir—Nervous system disorder—Doxorubicin—bone cancer	7.91e-05	0.000566	CcSEcCtD
Ritonavir—Thrombocytopenia—Doxorubicin—bone cancer	7.89e-05	0.000565	CcSEcCtD
Ritonavir—Insomnia—Epirubicin—bone cancer	7.88e-05	0.000564	CcSEcCtD
Ritonavir—Tachycardia—Doxorubicin—bone cancer	7.87e-05	0.000564	CcSEcCtD
Ritonavir—Skin disorder—Doxorubicin—bone cancer	7.83e-05	0.000561	CcSEcCtD
Ritonavir—Paraesthesia—Epirubicin—bone cancer	7.82e-05	0.00056	CcSEcCtD
Ritonavir—Hyperhidrosis—Doxorubicin—bone cancer	7.79e-05	0.000558	CcSEcCtD
Ritonavir—ABCG2—Transmembrane transport of small molecules—TUBB4B—bone cancer	7.79e-05	0.00127	CbGpPWpGaD
Ritonavir—Dyspnoea—Epirubicin—bone cancer	7.77e-05	0.000556	CcSEcCtD
Ritonavir—Somnolence—Epirubicin—bone cancer	7.75e-05	0.000555	CcSEcCtD
Ritonavir—ABCC2—Transmembrane transport of small molecules—TUBB2A—bone cancer	7.74e-05	0.00126	CbGpPWpGaD
Ritonavir—SLCO1A2—Metabolism—NDUFA12—bone cancer	7.7e-05	0.00125	CbGpPWpGaD
Ritonavir—Anorexia—Doxorubicin—bone cancer	7.69e-05	0.00055	CcSEcCtD
Ritonavir—Feeling abnormal—Methotrexate—bone cancer	7.67e-05	0.000549	CcSEcCtD
Ritonavir—Dyspepsia—Epirubicin—bone cancer	7.67e-05	0.000549	CcSEcCtD
Ritonavir—ABCC1—Transmembrane transport of small molecules—TUBB2A—bone cancer	7.65e-05	0.00125	CbGpPWpGaD
Ritonavir—Gastrointestinal pain—Methotrexate—bone cancer	7.61e-05	0.000545	CcSEcCtD
Ritonavir—Decreased appetite—Epirubicin—bone cancer	7.58e-05	0.000542	CcSEcCtD
Ritonavir—Hypotension—Doxorubicin—bone cancer	7.53e-05	0.00054	CcSEcCtD
Ritonavir—Gastrointestinal disorder—Epirubicin—bone cancer	7.52e-05	0.000539	CcSEcCtD
Ritonavir—Fatigue—Epirubicin—bone cancer	7.51e-05	0.000538	CcSEcCtD
Ritonavir—CYP2C8—Arachidonic acid metabolism—PTGS2—bone cancer	7.51e-05	0.00122	CbGpPWpGaD
Ritonavir—CYP2B6—Biological oxidations—CYP3A4—bone cancer	7.45e-05	0.00121	CbGpPWpGaD
Ritonavir—Pain—Epirubicin—bone cancer	7.45e-05	0.000534	CcSEcCtD
Ritonavir—Constipation—Epirubicin—bone cancer	7.45e-05	0.000534	CcSEcCtD
Ritonavir—Urticaria—Methotrexate—bone cancer	7.4e-05	0.00053	CcSEcCtD
Ritonavir—Body temperature increased—Methotrexate—bone cancer	7.36e-05	0.000527	CcSEcCtD
Ritonavir—Abdominal pain—Methotrexate—bone cancer	7.36e-05	0.000527	CcSEcCtD
Ritonavir—CYP2B6—Metapathway biotransformation—CYP3A4—bone cancer	7.35e-05	0.0012	CbGpPWpGaD
Ritonavir—Musculoskeletal discomfort—Doxorubicin—bone cancer	7.35e-05	0.000526	CcSEcCtD
Ritonavir—CYP2E1—Biological oxidations—CYP3A4—bone cancer	7.3e-05	0.00119	CbGpPWpGaD
Ritonavir—Insomnia—Doxorubicin—bone cancer	7.29e-05	0.000522	CcSEcCtD
Ritonavir—CYP3A5—Biological oxidations—CYP3A4—bone cancer	7.28e-05	0.00119	CbGpPWpGaD
Ritonavir—SLCO1B1—Transmembrane transport of small molecules—TUBB2A—bone cancer	7.27e-05	0.00118	CbGpPWpGaD
Ritonavir—Paraesthesia—Doxorubicin—bone cancer	7.24e-05	0.000518	CcSEcCtD
Ritonavir—CYP2E1—Metapathway biotransformation—CYP3A4—bone cancer	7.2e-05	0.00117	CbGpPWpGaD
Ritonavir—Dyspnoea—Doxorubicin—bone cancer	7.19e-05	0.000515	CcSEcCtD
Ritonavir—CYP3A5—Metapathway biotransformation—CYP3A4—bone cancer	7.18e-05	0.00117	CbGpPWpGaD
Ritonavir—Feeling abnormal—Epirubicin—bone cancer	7.18e-05	0.000514	CcSEcCtD
Ritonavir—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	7.17e-05	0.00117	CbGpPWpGaD
Ritonavir—Somnolence—Doxorubicin—bone cancer	7.17e-05	0.000513	CcSEcCtD
Ritonavir—Gastrointestinal pain—Epirubicin—bone cancer	7.13e-05	0.00051	CcSEcCtD
Ritonavir—Dyspepsia—Doxorubicin—bone cancer	7.1e-05	0.000508	CcSEcCtD
Ritonavir—Decreased appetite—Doxorubicin—bone cancer	7.01e-05	0.000502	CcSEcCtD
Ritonavir—Gastrointestinal disorder—Doxorubicin—bone cancer	6.96e-05	0.000498	CcSEcCtD
Ritonavir—Fatigue—Doxorubicin—bone cancer	6.95e-05	0.000498	CcSEcCtD
Ritonavir—ABCC1—Metabolism—NDUFA12—bone cancer	6.92e-05	0.00113	CbGpPWpGaD
Ritonavir—Urticaria—Epirubicin—bone cancer	6.92e-05	0.000496	CcSEcCtD
Ritonavir—Constipation—Doxorubicin—bone cancer	6.9e-05	0.000494	CcSEcCtD
Ritonavir—Pain—Doxorubicin—bone cancer	6.9e-05	0.000494	CcSEcCtD
Ritonavir—Abdominal pain—Epirubicin—bone cancer	6.89e-05	0.000493	CcSEcCtD
Ritonavir—Body temperature increased—Epirubicin—bone cancer	6.89e-05	0.000493	CcSEcCtD
Ritonavir—Hypersensitivity—Methotrexate—bone cancer	6.86e-05	0.000491	CcSEcCtD
Ritonavir—CYP1A2—Aryl Hydrocarbon Receptor—RB1—bone cancer	6.79e-05	0.00111	CbGpPWpGaD
Ritonavir—ABCG2—Transmembrane transport of small molecules—TUBB2A—bone cancer	6.73e-05	0.0011	CbGpPWpGaD
Ritonavir—CYP2C19—Arachidonic acid metabolism—PTGS2—bone cancer	6.7e-05	0.00109	CbGpPWpGaD
Ritonavir—Asthenia—Methotrexate—bone cancer	6.68e-05	0.000478	CcSEcCtD
Ritonavir—Feeling abnormal—Doxorubicin—bone cancer	6.64e-05	0.000476	CcSEcCtD
Ritonavir—Gastrointestinal pain—Doxorubicin—bone cancer	6.59e-05	0.000472	CcSEcCtD
Ritonavir—Pruritus—Methotrexate—bone cancer	6.59e-05	0.000472	CcSEcCtD
Ritonavir—SLCO1B1—Metabolism—NDUFA12—bone cancer	6.58e-05	0.00107	CbGpPWpGaD
Ritonavir—Hypersensitivity—Epirubicin—bone cancer	6.42e-05	0.00046	CcSEcCtD
Ritonavir—CYP1A2—Phase II conjugation—GSTP1—bone cancer	6.41e-05	0.00105	CbGpPWpGaD
Ritonavir—Urticaria—Doxorubicin—bone cancer	6.41e-05	0.000459	CcSEcCtD
Ritonavir—SLCO1A2—Metabolism—NT5C3A—bone cancer	6.38e-05	0.00104	CbGpPWpGaD
Ritonavir—Abdominal pain—Doxorubicin—bone cancer	6.37e-05	0.000456	CcSEcCtD
Ritonavir—Body temperature increased—Doxorubicin—bone cancer	6.37e-05	0.000456	CcSEcCtD
Ritonavir—CYP2B6—Biological oxidations—GSTP1—bone cancer	6.37e-05	0.00104	CbGpPWpGaD
Ritonavir—Diarrhoea—Methotrexate—bone cancer	6.37e-05	0.000456	CcSEcCtD
Ritonavir—CYP2C8—Biological oxidations—CYP3A4—bone cancer	6.31e-05	0.00103	CbGpPWpGaD
Ritonavir—CYP2B6—Metapathway biotransformation—GSTP1—bone cancer	6.29e-05	0.00102	CbGpPWpGaD
Ritonavir—Asthenia—Epirubicin—bone cancer	6.25e-05	0.000448	CcSEcCtD
Ritonavir—CYP2E1—Biological oxidations—GSTP1—bone cancer	6.24e-05	0.00102	CbGpPWpGaD
Ritonavir—CYP3A5—Biological oxidations—GSTP1—bone cancer	6.23e-05	0.00102	CbGpPWpGaD
Ritonavir—CYP2C8—Metapathway biotransformation—CYP3A4—bone cancer	6.22e-05	0.00101	CbGpPWpGaD
Ritonavir—Pruritus—Epirubicin—bone cancer	6.17e-05	0.000441	CcSEcCtD
Ritonavir—Dizziness—Methotrexate—bone cancer	6.16e-05	0.000441	CcSEcCtD
Ritonavir—CYP2E1—Metapathway biotransformation—GSTP1—bone cancer	6.16e-05	0.001	CbGpPWpGaD
Ritonavir—CYP3A5—Metapathway biotransformation—GSTP1—bone cancer	6.14e-05	0.001	CbGpPWpGaD
Ritonavir—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	6.11e-05	0.000996	CbGpPWpGaD
Ritonavir—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	6.1e-05	0.000994	CbGpPWpGaD
Ritonavir—ABCG2—Metabolism—NDUFA12—bone cancer	6.09e-05	0.000993	CbGpPWpGaD
Ritonavir—CYP3A7—Metabolism—NDUFA12—bone cancer	6.04e-05	0.000985	CbGpPWpGaD
Ritonavir—Diarrhoea—Epirubicin—bone cancer	5.96e-05	0.000427	CcSEcCtD
Ritonavir—Hypersensitivity—Doxorubicin—bone cancer	5.94e-05	0.000425	CcSEcCtD
Ritonavir—Vomiting—Methotrexate—bone cancer	5.92e-05	0.000424	CcSEcCtD
Ritonavir—Rash—Methotrexate—bone cancer	5.87e-05	0.00042	CcSEcCtD
Ritonavir—Dermatitis—Methotrexate—bone cancer	5.87e-05	0.00042	CcSEcCtD
Ritonavir—Headache—Methotrexate—bone cancer	5.83e-05	0.000418	CcSEcCtD
Ritonavir—CYP1A2—Tryptophan metabolism—MDM2—bone cancer	5.79e-05	0.000944	CbGpPWpGaD
Ritonavir—Asthenia—Doxorubicin—bone cancer	5.79e-05	0.000414	CcSEcCtD
Ritonavir—Dizziness—Epirubicin—bone cancer	5.76e-05	0.000413	CcSEcCtD
Ritonavir—ABCC1—Metabolism—NT5C3A—bone cancer	5.74e-05	0.000935	CbGpPWpGaD
Ritonavir—Pruritus—Doxorubicin—bone cancer	5.7e-05	0.000408	CcSEcCtD
Ritonavir—CYP2C19—Biological oxidations—CYP3A4—bone cancer	5.63e-05	0.000918	CbGpPWpGaD
Ritonavir—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	5.58e-05	0.00091	CbGpPWpGaD
Ritonavir—CYP2C19—Metapathway biotransformation—CYP3A4—bone cancer	5.55e-05	0.000905	CbGpPWpGaD
Ritonavir—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	5.55e-05	0.000905	CbGpPWpGaD
Ritonavir—Vomiting—Epirubicin—bone cancer	5.54e-05	0.000397	CcSEcCtD
Ritonavir—Nausea—Methotrexate—bone cancer	5.53e-05	0.000396	CcSEcCtD
Ritonavir—Diarrhoea—Doxorubicin—bone cancer	5.52e-05	0.000395	CcSEcCtD
Ritonavir—Rash—Epirubicin—bone cancer	5.49e-05	0.000393	CcSEcCtD
Ritonavir—Dermatitis—Epirubicin—bone cancer	5.49e-05	0.000393	CcSEcCtD
Ritonavir—Headache—Epirubicin—bone cancer	5.46e-05	0.000391	CcSEcCtD
Ritonavir—SLCO1B1—Metabolism—NT5C3A—bone cancer	5.45e-05	0.000889	CbGpPWpGaD
Ritonavir—CYP2C8—Biological oxidations—GSTP1—bone cancer	5.4e-05	0.00088	CbGpPWpGaD
Ritonavir—Dizziness—Doxorubicin—bone cancer	5.33e-05	0.000382	CcSEcCtD
Ritonavir—CYP2C8—Metapathway biotransformation—GSTP1—bone cancer	5.32e-05	0.000867	CbGpPWpGaD
Ritonavir—CYP1A2—Arachidonic acid metabolism—PTGS2—bone cancer	5.22e-05	0.000851	CbGpPWpGaD
Ritonavir—CYP2D6—Biological oxidations—CYP3A4—bone cancer	5.18e-05	0.000844	CbGpPWpGaD
Ritonavir—Nausea—Epirubicin—bone cancer	5.18e-05	0.000371	CcSEcCtD
Ritonavir—CYP2C9—Biological oxidations—CYP3A4—bone cancer	5.13e-05	0.000837	CbGpPWpGaD
Ritonavir—Vomiting—Doxorubicin—bone cancer	5.13e-05	0.000367	CcSEcCtD
Ritonavir—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	5.11e-05	0.000833	CbGpPWpGaD
Ritonavir—Rash—Doxorubicin—bone cancer	5.08e-05	0.000364	CcSEcCtD
Ritonavir—Dermatitis—Doxorubicin—bone cancer	5.08e-05	0.000364	CcSEcCtD
Ritonavir—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	5.06e-05	0.000825	CbGpPWpGaD
Ritonavir—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	5.05e-05	0.000824	CbGpPWpGaD
Ritonavir—Headache—Doxorubicin—bone cancer	5.05e-05	0.000362	CcSEcCtD
Ritonavir—ABCG2—Metabolism—NT5C3A—bone cancer	5.05e-05	0.000823	CbGpPWpGaD
Ritonavir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	5.03e-05	0.000821	CbGpPWpGaD
Ritonavir—CYP3A7—Metabolism—NT5C3A—bone cancer	5e-05	0.000816	CbGpPWpGaD
Ritonavir—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	4.99e-05	0.000813	CbGpPWpGaD
Ritonavir—CYP2C19—Biological oxidations—GSTP1—bone cancer	4.82e-05	0.000785	CbGpPWpGaD
Ritonavir—Nausea—Doxorubicin—bone cancer	4.79e-05	0.000343	CcSEcCtD
Ritonavir—CYP2C19—Metapathway biotransformation—GSTP1—bone cancer	4.75e-05	0.000774	CbGpPWpGaD
Ritonavir—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	4.72e-05	0.00077	CbGpPWpGaD
Ritonavir—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	4.47e-05	0.000729	CbGpPWpGaD
Ritonavir—CYP2B6—Metabolism—NDUFA12—bone cancer	4.47e-05	0.000728	CbGpPWpGaD
Ritonavir—CYP2D6—Biological oxidations—GSTP1—bone cancer	4.43e-05	0.000722	CbGpPWpGaD
Ritonavir—CYP2C9—Biological oxidations—GSTP1—bone cancer	4.39e-05	0.000716	CbGpPWpGaD
Ritonavir—CYP1A2—Biological oxidations—CYP3A4—bone cancer	4.39e-05	0.000715	CbGpPWpGaD
Ritonavir—CYP2E1—Metabolism—NDUFA12—bone cancer	4.37e-05	0.000713	CbGpPWpGaD
Ritonavir—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	4.37e-05	0.000712	CbGpPWpGaD
Ritonavir—CYP3A5—Metabolism—NDUFA12—bone cancer	4.37e-05	0.000712	CbGpPWpGaD
Ritonavir—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	4.33e-05	0.000706	CbGpPWpGaD
Ritonavir—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	4.33e-05	0.000705	CbGpPWpGaD
Ritonavir—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	4.23e-05	0.000689	CbGpPWpGaD
Ritonavir—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	4.21e-05	0.000687	CbGpPWpGaD
Ritonavir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	3.96e-05	0.000645	CbGpPWpGaD
Ritonavir—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	3.96e-05	0.000645	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism—NDUFA12—bone cancer	3.78e-05	0.000616	CbGpPWpGaD
Ritonavir—CYP1A2—Biological oxidations—GSTP1—bone cancer	3.75e-05	0.000612	CbGpPWpGaD
Ritonavir—CYP2B6—Metabolism—NT5C3A—bone cancer	3.7e-05	0.000603	CbGpPWpGaD
Ritonavir—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	3.7e-05	0.000603	CbGpPWpGaD
Ritonavir—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	3.64e-05	0.000593	CbGpPWpGaD
Ritonavir—CYP2E1—Metabolism—NT5C3A—bone cancer	3.63e-05	0.000591	CbGpPWpGaD
Ritonavir—CYP3A5—Metabolism—NT5C3A—bone cancer	3.62e-05	0.00059	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism—NDUFA12—bone cancer	3.38e-05	0.00055	CbGpPWpGaD
Ritonavir—ABCB1—Metabolism—NDUFA12—bone cancer	3.29e-05	0.000537	CbGpPWpGaD
Ritonavir—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	3.13e-05	0.000511	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism—NT5C3A—bone cancer	3.13e-05	0.000511	CbGpPWpGaD
Ritonavir—CYP2D6—Metabolism—NDUFA12—bone cancer	3.1e-05	0.000506	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism—NDUFA12—bone cancer	3.08e-05	0.000502	CbGpPWpGaD
Ritonavir—ABCC1—Disease—ENO2—bone cancer	3e-05	0.000489	CbGpPWpGaD
Ritonavir—CYP3A4—Biological oxidations—GSTP1—bone cancer	2.9e-05	0.000472	CbGpPWpGaD
Ritonavir—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	2.86e-05	0.000466	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism—NT5C3A—bone cancer	2.8e-05	0.000456	CbGpPWpGaD
Ritonavir—SLCO1A2—Metabolism—ENO2—bone cancer	2.79e-05	0.000455	CbGpPWpGaD
Ritonavir—ABCC1—Disease—DHFR—bone cancer	2.78e-05	0.000454	CbGpPWpGaD
Ritonavir—ABCB1—Metabolism—NT5C3A—bone cancer	2.73e-05	0.000445	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism—NDUFA12—bone cancer	2.63e-05	0.000429	CbGpPWpGaD
Ritonavir—SLCO1A2—Metabolism—DHFR—bone cancer	2.59e-05	0.000422	CbGpPWpGaD
Ritonavir—CYP2D6—Metabolism—NT5C3A—bone cancer	2.57e-05	0.000419	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism—NT5C3A—bone cancer	2.55e-05	0.000416	CbGpPWpGaD
Ritonavir—ABCC1—Metabolism—ENO2—bone cancer	2.51e-05	0.00041	CbGpPWpGaD
Ritonavir—SLCO1A2—Metabolism—GNA11—bone cancer	2.42e-05	0.000395	CbGpPWpGaD
Ritonavir—SLCO1B1—Metabolism—ENO2—bone cancer	2.39e-05	0.000389	CbGpPWpGaD
Ritonavir—ABCC1—Metabolism—DHFR—bone cancer	2.33e-05	0.00038	CbGpPWpGaD
Ritonavir—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	2.32e-05	0.000379	CbGpPWpGaD
Ritonavir—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	2.24e-05	0.000365	CbGpPWpGaD
Ritonavir—SLCO1B1—Metabolism—DHFR—bone cancer	2.22e-05	0.000361	CbGpPWpGaD
Ritonavir—ABCG2—Metabolism—ENO2—bone cancer	2.21e-05	0.000361	CbGpPWpGaD
Ritonavir—SLCO1A2—Metabolism—CYP3A4—bone cancer	2.2e-05	0.000358	CbGpPWpGaD
Ritonavir—CYP3A7—Metabolism—ENO2—bone cancer	2.19e-05	0.000357	CbGpPWpGaD
Ritonavir—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.18e-05	0.000356	CbGpPWpGaD
Ritonavir—ABCC1—Metabolism—GNA11—bone cancer	2.18e-05	0.000355	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism—NT5C3A—bone cancer	2.18e-05	0.000355	CbGpPWpGaD
Ritonavir—SLCO1B1—Metabolism—GNA11—bone cancer	2.07e-05	0.000338	CbGpPWpGaD
Ritonavir—ABCG2—Metabolism—DHFR—bone cancer	2.05e-05	0.000334	CbGpPWpGaD
Ritonavir—CYP3A7—Metabolism—DHFR—bone cancer	2.03e-05	0.000332	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—NDUFA12—bone cancer	2.03e-05	0.000331	CbGpPWpGaD
Ritonavir—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	2.02e-05	0.000329	CbGpPWpGaD
Ritonavir—ABCC1—Disease—TGFBR2—bone cancer	2.02e-05	0.000329	CbGpPWpGaD
Ritonavir—ABCC1—Metabolism—CYP3A4—bone cancer	1.98e-05	0.000322	CbGpPWpGaD
Ritonavir—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.97e-05	0.00032	CbGpPWpGaD
Ritonavir—ABCG2—Metabolism—GNA11—bone cancer	1.92e-05	0.000313	CbGpPWpGaD
Ritonavir—CYP3A7—Metabolism—GNA11—bone cancer	1.9e-05	0.00031	CbGpPWpGaD
Ritonavir—SLCO1A2—Metabolism—GSTP1—bone cancer	1.88e-05	0.000306	CbGpPWpGaD
Ritonavir—SLCO1B1—Metabolism—CYP3A4—bone cancer	1.88e-05	0.000306	CbGpPWpGaD
Ritonavir—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.87e-05	0.000305	CbGpPWpGaD
Ritonavir—ABCG2—Metabolism—CYP3A4—bone cancer	1.74e-05	0.000283	CbGpPWpGaD
Ritonavir—CYP3A7—Metabolism—CYP3A4—bone cancer	1.72e-05	0.000281	CbGpPWpGaD
Ritonavir—ABCC1—Metabolism—GSTP1—bone cancer	1.69e-05	0.000275	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—NT5C3A—bone cancer	1.68e-05	0.000274	CbGpPWpGaD
Ritonavir—CYP2B6—Metabolism—ENO2—bone cancer	1.62e-05	0.000264	CbGpPWpGaD
Ritonavir—SLCO1B1—Metabolism—GSTP1—bone cancer	1.61e-05	0.000262	CbGpPWpGaD
Ritonavir—CYP2E1—Metabolism—ENO2—bone cancer	1.59e-05	0.000259	CbGpPWpGaD
Ritonavir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	1.59e-05	0.000259	CbGpPWpGaD
Ritonavir—CYP3A5—Metabolism—ENO2—bone cancer	1.58e-05	0.000258	CbGpPWpGaD
Ritonavir—CYP2B6—Metabolism—DHFR—bone cancer	1.5e-05	0.000245	CbGpPWpGaD
Ritonavir—ABCG2—Metabolism—GSTP1—bone cancer	1.49e-05	0.000242	CbGpPWpGaD
Ritonavir—CYP3A7—Metabolism—GSTP1—bone cancer	1.47e-05	0.00024	CbGpPWpGaD
Ritonavir—CYP2E1—Metabolism—DHFR—bone cancer	1.47e-05	0.00024	CbGpPWpGaD
Ritonavir—CYP3A5—Metabolism—DHFR—bone cancer	1.47e-05	0.00024	CbGpPWpGaD
Ritonavir—CYP2B6—Metabolism—GNA11—bone cancer	1.41e-05	0.000229	CbGpPWpGaD
Ritonavir—ABCC1—Disease—KIT—bone cancer	1.38e-05	0.000224	CbGpPWpGaD
Ritonavir—CYP2E1—Metabolism—GNA11—bone cancer	1.38e-05	0.000224	CbGpPWpGaD
Ritonavir—CYP3A5—Metabolism—GNA11—bone cancer	1.37e-05	0.000224	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism—ENO2—bone cancer	1.37e-05	0.000224	CbGpPWpGaD
Ritonavir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	1.33e-05	0.000217	CbGpPWpGaD
Ritonavir—ABCC1—Disease—BRAF—bone cancer	1.29e-05	0.000211	CbGpPWpGaD
Ritonavir—CYP2B6—Metabolism—CYP3A4—bone cancer	1.27e-05	0.000208	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism—DHFR—bone cancer	1.27e-05	0.000208	CbGpPWpGaD
Ritonavir—CYP2E1—Metabolism—CYP3A4—bone cancer	1.25e-05	0.000203	CbGpPWpGaD
Ritonavir—CYP3A5—Metabolism—CYP3A4—bone cancer	1.25e-05	0.000203	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism—ENO2—bone cancer	1.23e-05	0.0002	CbGpPWpGaD
Ritonavir—ABCB1—Metabolism—ENO2—bone cancer	1.2e-05	0.000195	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism—GNA11—bone cancer	1.19e-05	0.000194	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism—DHFR—bone cancer	1.14e-05	0.000185	CbGpPWpGaD
Ritonavir—CYP2D6—Metabolism—ENO2—bone cancer	1.13e-05	0.000184	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism—ENO2—bone cancer	1.12e-05	0.000182	CbGpPWpGaD
Ritonavir—ABCB1—Metabolism—DHFR—bone cancer	1.11e-05	0.000181	CbGpPWpGaD
Ritonavir—CYP2B6—Metabolism—GSTP1—bone cancer	1.09e-05	0.000178	CbGpPWpGaD
Ritonavir—ABCC1—Disease—MDM2—bone cancer	1.08e-05	0.000177	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism—CYP3A4—bone cancer	1.08e-05	0.000176	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.07e-05	0.000175	CbGpPWpGaD
Ritonavir—CYP2E1—Metabolism—GSTP1—bone cancer	1.07e-05	0.000174	CbGpPWpGaD
Ritonavir—CYP3A5—Metabolism—GSTP1—bone cancer	1.07e-05	0.000174	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism—GNA11—bone cancer	1.06e-05	0.000173	CbGpPWpGaD
Ritonavir—CYP2D6—Metabolism—DHFR—bone cancer	1.05e-05	0.00017	CbGpPWpGaD
Ritonavir—ABCC1—Disease—PTGS2—bone cancer	1.05e-05	0.00017	CbGpPWpGaD
Ritonavir—ABCB1—Metabolism—GNA11—bone cancer	1.04e-05	0.000169	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism—DHFR—bone cancer	1.04e-05	0.000169	CbGpPWpGaD
Ritonavir—CYP2D6—Metabolism—GNA11—bone cancer	9.77e-06	0.000159	CbGpPWpGaD
Ritonavir—SLCO1A2—Metabolism—PTGS2—bone cancer	9.73e-06	0.000159	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism—GNA11—bone cancer	9.69e-06	0.000158	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism—CYP3A4—bone cancer	9.63e-06	0.000157	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	9.58e-06	0.000156	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism—ENO2—bone cancer	9.55e-06	0.000156	CbGpPWpGaD
Ritonavir—ABCB1—Metabolism—CYP3A4—bone cancer	9.4e-06	0.000153	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism—GSTP1—bone cancer	9.23e-06	0.00015	CbGpPWpGaD
Ritonavir—CYP2D6—Metabolism—CYP3A4—bone cancer	8.86e-06	0.000144	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism—DHFR—bone cancer	8.86e-06	0.000144	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism—CYP3A4—bone cancer	8.78e-06	0.000143	CbGpPWpGaD
Ritonavir—ABCC1—Metabolism—PTGS2—bone cancer	8.75e-06	0.000143	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	8.74e-06	0.000142	CbGpPWpGaD
Ritonavir—SLCO1B1—Metabolism—PTGS2—bone cancer	8.32e-06	0.000136	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism—GNA11—bone cancer	8.28e-06	0.000135	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism—GSTP1—bone cancer	8.24e-06	0.000134	CbGpPWpGaD
Ritonavir—ABCB1—Metabolism—GSTP1—bone cancer	8.04e-06	0.000131	CbGpPWpGaD
Ritonavir—ABCG2—Metabolism—PTGS2—bone cancer	7.7e-06	0.000126	CbGpPWpGaD
Ritonavir—CYP3A7—Metabolism—PTGS2—bone cancer	7.64e-06	0.000124	CbGpPWpGaD
Ritonavir—CYP2D6—Metabolism—GSTP1—bone cancer	7.58e-06	0.000123	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism—GSTP1—bone cancer	7.51e-06	0.000122	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism—CYP3A4—bone cancer	7.5e-06	0.000122	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	7.47e-06	0.000122	CbGpPWpGaD
Ritonavir—ABCC1—Disease—EGFR—bone cancer	7.41e-06	0.000121	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—ENO2—bone cancer	7.37e-06	0.00012	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—DHFR—bone cancer	6.83e-06	0.000111	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism—GSTP1—bone cancer	6.42e-06	0.000105	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—GNA11—bone cancer	6.39e-06	0.000104	CbGpPWpGaD
Ritonavir—CYP2B6—Metabolism—PTGS2—bone cancer	5.65e-06	9.2e-05	CbGpPWpGaD
Ritonavir—CYP2E1—Metabolism—PTGS2—bone cancer	5.53e-06	9.02e-05	CbGpPWpGaD
Ritonavir—CYP3A5—Metabolism—PTGS2—bone cancer	5.52e-06	9e-05	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—GSTP1—bone cancer	4.95e-06	8.07e-05	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism—PTGS2—bone cancer	4.78e-06	7.79e-05	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism—PTGS2—bone cancer	4.27e-06	6.96e-05	CbGpPWpGaD
Ritonavir—ABCB1—Metabolism—PTGS2—bone cancer	4.16e-06	6.79e-05	CbGpPWpGaD
Ritonavir—CYP2D6—Metabolism—PTGS2—bone cancer	3.92e-06	6.4e-05	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism—PTGS2—bone cancer	3.89e-06	6.34e-05	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism—PTGS2—bone cancer	3.32e-06	5.42e-05	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—PTGS2—bone cancer	2.57e-06	4.18e-05	CbGpPWpGaD
